Field safety notices: Given Imaging Inc.
Manufacturer registered in EUDAMED: SRN US-MF-000019982 ; country: United States
5 authority publications by 4 authorities, from 16 Apr 2021 to 17 Aug 2026.
Latest notice: 17 Aug 2026, ANSM, Dispositif de pose de capsule CF Bravo, 1-pk (FGS-0636), 5-pk (FGS-0635)
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Given Imaging Inc. or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
3 distinct corrective actions.
Corrective action: 3 publications by ANSM, IGJ, MHRA, from 11 Aug 2026 to 17 Aug 2026
- Dispositif de pose de capsule CF Bravo, 1-pk (FGS-0636), 5-pk (FGS-0635)
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- IGJNetherlandsofficial source: Given Imaging Inc-Bravo CF capsule delivery dev 1-pk FGS- and 5-pk FGS, IGJ, 2026-08-14Given Imaging Inc-Bravo CF capsule delivery dev 1-pk FGS- and 5-pk FGS
Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 17 Nov 2026
- MHRAUnited Kingdomofficial source: Bravo CF capsule delivery, MHRA, 2026-08-11Bravo CF capsule deliveryModels, lots, UDI: FGS-0635, FGS-0636
Source: MHRA, Field Safety Notices, gov.uk (Open Government Licence v3.0) Contains public sector information licensed under the Open Government Licence v3.0. · collected 16 Nov 2026
- Capsule Bravo sans calibration
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- CÁPSULA BRAVO PH DELIVERY DEV (código de producto FGS-0312) y CÁPSULA BRAVO CF DELIVERY DEV (código de producto FGS-0635)
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026